CIK 0001745999 · Large accelerated filer
Beam Therapeutics Inc.
Sign in to watch- Ticker
- BEAM
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 857-327-8775
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Former names
- Beam Therapeutics Inc.
- 4 Planned sale Chief Medical Officer sold 30,563 shares at an average $17.92 ($547,835)
- 4 Grant or award Chief Legal Officer acquired 20,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 27,500 shares (grant or award)
- 4 Grant or award President acquired 35,000 shares (grant or award)
- 4 Grant or award SVP, Finance and Treasurer acquired 10,000 shares (grant or award)
- 4 Grant or award CEO acquired 77,500 shares (grant or award)
- 144 Insider Sale of Securities
- 4/A Option exercise CEO acquired 30,000 shares (option exercise)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Other events
- FWP Offering Free Writing Prospectus
- 424B5 Offering Prospectus
- 8-K Event Regulation FD disclosure · Other events
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
Page 7 of 26 · 514 filings